Invivyd Announces Positive 180-day Clinical Efficacy Data From CANOPY Phase 3 Trial Of Pemivibart

RTTNews | 131 दिनों पहले
Invivyd Announces Positive 180-day Clinical Efficacy Data From CANOPY Phase 3 Trial Of Pemivibart

(RTTNews) - Biopharmaceutical company Invivyd, Inc. (IVVD) announced Tuesday positive 180-day clinical efficacy data from the company's ongoing CANOPY Phase 3 clinical trial of pemivibart, a half-life extended investigational monoclonal antibody (mAb), for the pre-exposure prophylaxis (PrEP) of COVID-19.

The exploratory clinical efficacy data in Cohort B, a placebo-controlled cohort of all-comer immunocompetent individuals, showed a relative risk reduction of 84% with pemivibart compared to placebo in the likelihood of trial participants contracting confirmed symptomatic COVID-19, with no hospitalizations or deaths due to COVID-19 reported.

Cohort B participants treated with pemivibart experienced a 1.9% rate of symptomatic COVID-19 across a 180-day time period, whereas Cohort B participants in the placebo arm experienced an 11.9% rate of symptomatic COVID-19, a robust attack rate for the trial. Cases of COVID-19 observed in the pemivibart arm were mild or moderate in severity.

Additionally, in Cohort A, the single-arm immunocompromised cohort of the trial, pemivibart demonstrated a 3% rate of confirmed symptomatic COVID-19 over the 180-day period. Cases of COVID-19 observed in this cohort were also mild or moderate in severity.

These exploratory data support the concept of potential protection observed with pemivibart, aligned with expectations of a highly active prophylactic monoclonal antibody in this population.

The safety profile of pemivibart in the second half of the assessed 180-day time period remained consistent with previously disclosed CANOPY clinical trial data.

The 180-day clinical efficacy exploratory data announced today complements the initial clinical efficacy exploratory data demonstrating potential signals of clinical protection from symptomatic COVID-19 shared previously.

टैग: IVVD
read more
Invivyd Appoints William Duke As New CFO

Invivyd Appoints William Duke As New CFO

Biopharmaceutical company Invivyd, Inc. (IVVD) announced Tuesday the appointment of William Duke as Chief Financial Officer. Duke will lead Invivyd's financial strategy to support the company's continued growth.
RTTNews | 488 दिनों पहले
Hong Kong Private Sector Ebbs In December - S&P Global

Hong Kong Private Sector Ebbs In December - S&P Global

The private sector in Singapore continued to expand in December, albeit at a slower pace, the latest survey from S&P Global revealed on Monday with a PMI score of 51.1.
RTTNews | 5घंटे 2 मिनट पहले
Singapore Private Sector Slows In December - S&P Global

Singapore Private Sector Slows In December - S&P Global

The private sector in Singapore continued to expand in December, albeit at a slower pace, the latest survey from S&P Global revealed on Monday with a PMI score of 51.5.
RTTNews | 5घंटे 4 मिनट पहले
Taiwan Bourse May Challenge Resistance At 23,000 Points

Taiwan Bourse May Challenge Resistance At 23,000 Points

The Taiwan stock market on Friday halted the three-day slide in which it had stumbled more than 425 points or 2 percent. The Taiwan Stock Exchange now sits just above the 22,900-point plateau and it's tipped to open in the green again on Monday.
RTTNews | 5घंटे 14 मिनट पहले
Win Streak May Continue For Singapore Stock Market

Win Streak May Continue For Singapore Stock Market

The Singapore stock market has moved higher in back-to-back sessions, gathering almost 15 points or 0.4 percent along the way. The Straits Tines Index now rests just above the 3,800-point plateau and it's expected to extend its gains on Monday.
RTTNews | 5घंटे 44 मिनट पहले
Australia Services PMI Improves To 50.8 - S%P Global

Australia Services PMI Improves To 50.8 - S%P Global

The services sector in Australia continued to expand in December, and at a faster rate, the latest survey from S&P Global revealed on Monday with a services PMI score of 50.8.
RTTNews | 5घंटे 52 मिनट पहले
Malaysia Bourse Poised To End Losing Streak

Malaysia Bourse Poised To End Losing Streak

The Malaysia stock market has finished lower in consecutive trading days, sinking more than a dozen points or 0.7 percent in that span. The Kuala Lumpur Composite Index now rests just shy of the 1,630-point plateau although it may stop the bleeding on Monday.
RTTNews | 6घंटे 14 मिनट पहले